Animal immune systems' capacity to make antibodies that attach to antigens selectively can be used to create probes for detecting substances of interest in several experimental and analytical functions. No other contemporary method allows researchers to develop and produce molecular recognition tools with such excellent specificity.
Antibody technology is used by nearly all medical and cell biology scientists to perform molecular analysis. The extent to which scientists are concerned with antibody synthesis and purification will vary depending on their research demands. Therefore, let us look into the industrial production of antibodies for research-based applications.
Understanding Antibodies
Antibodies are immune system proteins that take the form of folded polypeptides or strands of amino acids with specific sequences that recognize a particular antigen's binding site. The body's B-lymphocytes produce antibodies, which circulate throughout the bloodstream and lymphatic system, attaching to their target antigens and neutralizing them.
Antibodies are particularly well-suited to function as probes due to several critical characteristics, most notably their high specificity. This level of precision is currently unmatched by other molecular recognition tools, making antibodies indispensable for both research and clinical diagnostics.
Custom Antibody Production
In biotech and biosensor development, the specificity of antibody-antigen recognition has several applications. These applications require extremely pure antibody sources. Antibodies are frequently attached to sensor surfaces to detect antigens or used with tagged detection platforms for antigen identification. A wide range of commercially accessible, purified antibodies with high antigen specificity is now available.
Based on how they are produced and extracted, these custom antibodies are classified as polyclonal or monoclonal. Polyclonal antibodies can recognize multiple epitopes, or locations, on an antigen. Monoclonal antibodies are derived from a specific B-cell line and recognize only one specific antigen epitope.
While antibodies are made naturally by the body, they can also be generated via custom antibody production. Custom antibody production requires a high purity level, which is often achieved using at least 4mg of immunogen to ensure a robust immune response.
Custom Polyclonal Antibodies
Custom polyclonal antibodies can be produced using animals such as goats, rats, mice, or chickens, typically following an 80-day protocol. Rabbits are often preferred in the custom polyclonal production process because they yield reliable volumes of high-quality, high-affinity antibodies from their antisera. Using rabbits is also cost-effective and efficient; unlike some other animals, rabbits often produce a more robust antibody response due to their strong sensitivity to antigens.
On the other hand, rats and mice are ideal when only a small amount of antiserum is required. Although goats can produce large volumes of antibodies, they may sometimes have a lower response rate to certain antigens compared to smaller mammals.
The 5-Step Method of Producing Antibodies
- Antigen Preparation
- Immunization & Hybridoma Development
- Hybridoma Fusion
- Subcloning
- Monoclonal Production & Purification
Antigen Preparation: While research departments must utilize high-quality, pure proteins or peptides, they can also synthesize their own custom peptides.
Immunization: The selected animals are immunized and then monitored for the production of target antibodies.
Fusion: Animals that demonstrate a strong immune response are selected for the fusion stage. The spleen is then harvested, and its B-cells are fused with myeloma cells to create hybridomas.
Subcloning: In this stage, the hybridoma cells are cloned several times to ensure the production of pure, monoclonal antibodies for homogeneity.
Production & purification: The protein production service involves separating the target antibodies from other proteins to ensure a high-quality final product.
A successful custom antibody production service necessitates meticulous preparation and execution of numerous critical procedures:
-
Purifying or synthesizing the target protein.
-
Selecting an immunogenic carrier protein.
-
Combining the antigen with the carrier protein creates a potent immunogen.
-
Using a suitable timetable and adjuvant mixture to immunize the animals.
-
Determining antibody titer and isotype by screening the serum (antibody characterization).
Antibody Purification
Bioresearch and diagnostic technologies have been transformed by the development of antibodies for use as sensor substrates and purification ligands. Animals immunized with prepared antigens will generate antibodies specific to that antigen. Once purified, these antibodies are ready to be utilized to detect recombinant protein expressions or the target antigen proteins in Western blot analysis, E. coli expression systems, and several other research activities. Protein expression and purification services can be classified as follows, ranging from general to highly specific:
-
Separation of total immunoglobulins from a subset of other proteins in the sample.
-
The use of abiotic ligands placed on solid surfaces to attach to certain antibody types (e.g., Protein A/G purification).
-
Antigen-specific affinity purification, which isolates all antigen-binding antibodies regardless of antibody class or isotype.
Antibody Characterization
Antibody characterization is crucial after protein expression, especially in biopharmaceutical development and research. Because diverse alterations occur throughout different synthesis phases, all therapeutic proteins synthesized using current methods exhibit variations in the final product. Because of these heterogeneities, extensive characterization is required for repeatable, safe, and effective therapeutic protein synthesis.
Simple Western analysis can determine the binding affinities of monoclonal and polyclonal antibodies, which is necessary for monoclonal antibody sequencing. This allows the relative specificity of the antibody to the protein of interest to be tracked. For clonal antibody screening, extremely small nanoliter amounts of material can be employed.
Comprehensive studies give researchers the information needed to choose appropriate solvents and additional compounds for specific applications and how to purify the antibody properly.
-
Antibody Identification: Samples with antigen-binding specificity are identified through screening.
-
Titering: A technique for determining antibody concentration and its effectiveness in a functional test.
-
Isotyping: The process of identifying a monoclonal antibody's specific class and subclass (e.g., IgG1 vs. IgG2).
Antibody Fragmentation
Antibody fragments are compact and straightforward constructs that have gained popularity in recent years due to their numerous advantages over the use of complete antibodies. Although whole antibodies are appropriate for most immunoassay procedures, antibody fragments—such as Fab (Antigen-binding fragments)—improve the performance of specific techniques. Antigen-binding fragments come in various formats; however, they invariably comprise at least the variable regions of both immunoglobulin chains. To preserve the antibody's binding site, disulfide bonds hold the structure intact.
Because there is limited demand for certain specific fragments, primary antibodies are rarely sold commercially as ready-made pieces. Consequently, each lab must often produce its own supply of these fragments.
Labeling and Immobilization of Antibodies
Antibodies can also be covalently modified to meet the needs of a specific study. Many immunological approaches require labeled antibodies, and several chemicals have been developed to facilitate this process. The antibody specificity used in affinity purification techniques relies on processes for attaching or immobilizing them to a chromatographic medium. These techniques utilize the same principles and chemical processes as antibody labeling. Understanding the molecular structure and functional groups on an antibody is essential for selecting the optimum strategy for modification, whether it involves labeling, crosslinking, or covalent immobilization.
The Science Behind Antibody Sequencing
An isolated polypeptide or glutamate is a sequence of amino acids organized linearly. The carboxylate (N) end of a protein's primary structure is constantly influenced by the hydroxyl (C) end. Peptide Synthesis may be sequenced or inferred from its DNA chronology, depending on the method used. In protein sequencing, identifying and studying the fatty acid phylogeny of proteins is called "protein sequencing."
Edman degradation, mass spectrometry, and bioinformatics extrapolation from the original DNA or mRNA sequence are used for antibody sequencing. When representing the amino acid order in a primary structure from the amino-terminal to the carboxyl-terminal end, single-letter or three-letter codes are commonly used. Depending on the standardized nomenclature, there is a code for each amino acid.
It is known that there are twenty different standard amino acids present in nature. Examples include glutamic acid, arginine, and asparagine (Glu/E, Arg/R, and Asn/N). Notably, amino acids are the building blocks of proteins and should not be confused with fatty acids or antibiotics.
Protein Sequencing techniques
The amino acid sequences of proteins may be determined using two well-established procedures. Because of its accuracy and speed, mass spectrometry has become the most regularly used approach in recent years. The second strategy, Edman degradation using a polypeptide sequenator, remains highly effective when the protein's N-terminus needs to be explicitly defined.
Mass Spectrometry
An increasingly popular proteomic technique uses mass spectrometry to decode proteins, a method that has become generally recognized for its precision. Peptides can be separated when enzymes and other chemicals break down proteins. Afterward, fractions containing various peptides are analyzed using an automated mass spectrometer that employs collision-induced dissociation (CID). The study results on soluble polypeptides, such as those derived from protease preparations, and the interpretation of the collision-induced dissociation mass spectra are essential for accurate sequencing.
Edman Degradation
Edman degradation is a process for sequencing proteins that involves removing one amino acid at a time from the N-terminal of the protein chain. Pehr Edman developed a unique method of flagging and cleaving the polypeptide to address the difficulty of harsh hydrolysis conditions that were detrimental to the protein's structure. Edman devised a technique for removing just one residue from a sequence while keeping the rest of the peptide intact.
A phenylthiocarbamoyl derivative is synthesized by reacting phenyl isothiocyanate (PITC) with the N-terminus. Under mildly acidic circumstances, the N-terminal residue is cleaved, resulting in the formation of a cyclic phenylthiohydantoin (PTH)-amino acid derivative, which can then be identified.
Single-molecule Protein Sequencing
One of the most recent emerging protein sequencing technologies has been developed using a TIRF (Total Internal Reflection Fluorescence) chamber to anchor peptides after covalently labeling specific amino acids with fluorophores. Through the use of TIRF, each individual peptide is imaged. Edman degradation is then used to release the N-terminal amino acid, resulting in a shortened polypeptide with a newly exposed free N-terminus.
The locations of fluorescent dyes inside each molecule are disclosed by a series of chemical reactions performed in sequence. According to results obtained for around 3 million biomolecules in 6.5 mm² sections of a coverslip, vast quantities of a given polypeptide may be examined concurrently at appropriate attachment densities.
It is possible to achieve images with high accuracy of up to 19 nanometers. Single-molecule localization microscopy (SMLM) uses the center position of a single fluorescent molecule—determined with more accuracy than the diffraction limit—to determine its exact location. Achieving the same degree of precision in the axial (3rd) plane, on the other hand, continues to be a challenge.
When using a TIRF microscope, researchers can employ a photometric method to determine the axial position of individual molecules. This can be combined with dual-color efforts to improve three-dimensional imaging with nanometric precision that is consistent in all directions.
SIMPLER (Single-molecule Photometric Localization of Energy Research) may be used in almost any experiment requiring a regular TIRF SMLM microscope immediately. A new era of study into the development and dynamics of intracellular features and protein-protein interactions has begun due to the affordability of 3D nanoscopy to a wide range of users.
Importance of Custom Antibody Production
Production of custom antibodies is essential when dealing with a rare or novel antigen. The resulting hybridoma cell line can be preserved for future use. Therefore, the production of custom antibodies can save considerable time in the future since the specific clones are already stored.
Selecting the Right Parameters:
- Production Yield: Researchers choose suitable species to produce large quantities of antibodies. Researchers determine the amount of antigen needed based on the anticipated quantity of antibodies required.
- Production Animals: Rats, mice, and goats are commonly preferred because their antibody isotypes are well-characterized. When selecting an animal, researchers should focus on its age and health condition. In general, very young animals should be avoided because their immune systems are not yet fully developed; however, excessively older animals are also avoided as their immune responses decline with age.
- Pre-clinical and Clinical Trials: Trials are vital for ensuring the effectiveness of antibody therapeutics in neutralizing antigens. Pre-clinical trials help researchers identify an antibody's possible reactions and safety profile before use in human beings.
Antibody Varieties
Different types of antibodies require different periods to be completed and delivered. For instance, polyclonal antibodies typically take 7 to 12 weeks, depending on the sequence of the antigen used. The protein is analyzed using bioinformatics to establish the proper structure.
When a research team orders monoclonal antibodies, the delivery time can range between 3 and 5 months. Algorithmic analysis can also identify the optimal combination based on the target yield in this process. Both protein antigens and peptides can be utilized to produce high-quality monoclonal antibodies.
In Summary
One option accessible to pharma businesses is to partner with a technology vendor. Outsourcing antibody production can be profitable, especially if a biomedical firm prefers to acquire compounds later in the development process instead of navigating the risks of internal R&D.
Outsourcing, on the other hand, is not without its drawbacks. The management of outsourcing can grow so complicated that it negates potential cost savings, while disbanding internal R&D teams might erode a company's core expertise. As a result, it's critical to think carefully about how to select the ideal outsourcing partner.